EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosisAL amyloidosis14 June 2020
MPE webinar on the impact of myeloma and AL amyloidosis in carers. What are the issues and challenges?AL amyloidosis, MPE, Myeloma8 May 2020
MPE webinar on personalised medicines in myeloma and AL amyloidosisAL amyloidosis, MPE, Myeloma28 April 2020
Watch the webinar on ASH 2019 highlights held yesterday by Myeloma Patients Europe (MPE)AL amyloidosis, Conferences, MPE, Myeloma, Videos15 January 2020
MPE webinar on ASH 2019 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, Myeloma20 December 2019
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosis6 June 2019
